Journal
ACS CHEMICAL BIOLOGY
Volume 8, Issue 12, Pages 2688-2696Publisher
AMER CHEMICAL SOC
DOI: 10.1021/cb400575t
Keywords
-
Categories
Funding
- Coopol innovation France-Chine program
- Medical Research Council [G500643, G0600801]
- ADR from the Region Rhone-Alpes [ARC1]
- University of Warwick Ph.D. studentship
- Medical Research Council [G0600801] Funding Source: researchfish
- MRC [G0600801] Funding Source: UKRI
Ask authors/readers for more resources
Understanding the molecular basis of bacterial cell wall assembly is of paramount importance in addressing the threat of increasing antibiotic resistance worldwide. Streptococcus pneumoniae presents a particularly acute problem in this respect, as it is capable of rapid evolution by homologous recombination with related species. Resistant strains selected by treatment with beta-lactams express variants of the target enzymes that do not recognize the drugs but retain their activity in cell wall building, despite the antibiotics being mimics of the natural substrate.. Until now, the crucial transpeptidase activity that is inhibited by beta-lactams was not amenable to in vitro investigation with enzymes from Gram-positive organisms, including streptococci, staphylococci, or enterococci pathogens. We report here for the first time the in vitro assembly of peptidoglycan using recombinant penicillin-binding proteins from pneumococcus and the precursor lipid II. The two required enzymatic activities, glycosyl transferase for elongating glycan chains and transpeptidase for cross-linking stem-peptides, were observed. Most importantly, the transpeptidase activity was dependent on the chemical nature of the stem-peptide. Amidation of the second residue glutamate into iso-glutamine by the recently discovered amido-transferase MurT/GatD is required for efficient cross-linking of the peptidoglycan.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available